LaraEmilyDavisMDOncologist, Medical & Pediatric

Clinical Trials

• SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes Start of enrollment: 2014 Jul 01

  Completed

  Phase 2

• A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma Start of enrollment: 2015 Sep 14

  Active, not recruiting

  Phase 3

• A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma Start of enrollment: 2015 Dec 22

  Completed

  Phase 2

• Selinexor in Advanced Liposarcoma Start of enrollment: 2016 Jan 04

  Completed

  Phase 2, Phase 3

• Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery Start of enrollment: 2017 Mar 10

  Completed

  Phase 1

• Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery Start of enrollment: 2018 Mar 19

  Active, not recruiting

  Phase 1

• Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma Start of enrollment: 2019 Dec 19

  Recruiting

  Phase 3

• Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma Start of enrollment: 2019 Mar 27

  Recruiting

  Early Phase 1

  Roles: Principal Investigator, Contact

• SMMART Adaptive Clinical Treatment (ACT) Trial Start of enrollment: 2023 Jan 30

  Withdrawn

  Early Phase 1

  Roles: Principal Investigator, Contact

• To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue Start of enrollment: 2021 Sep 01

  Completed

  Phase 1, Phase 2

  Roles: Principal Investigator, Contact

• Join now to see all